P53- and mevalonate pathway–driven malignancies require Arf6 for metastasis and drug resistance

Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer

(2016) Shigeru Hashimoto et al.   Nature Communications

N-Oxide derivatives of 3-(3-pyridyl)-2-phosphonopropanoic acids as potential inhibitors of Rab geranylgeranylation

(2015) Xiang Zhou et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer

(2015) Xiaofeng Zheng et al.   NATURE

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

(2015) Kari R. Fischer et al.   NATURE

HER2-family signalling mechanisms, clinical implications and targeting in breast cancer

(2014) N. Elster et al.   BREAST CANCER RESEARCH AND TREATMENT

High level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patients

(2014) Hiroki Sato et al.   Cell Communication and Signaling

Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease

(2014) Behzad Yeganeh et al.   PHARMACOLOGY & THERAPEUTICS

Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling

(2013) Thomas W. Grunt et al.   CURRENT CANCER DRUG TARGETS

Mechanisms that link the oncogenic epithelial–mesenchymal transition to suppression of anoikis

(2013) Steven M. Frisch et al.   JOURNAL OF CELL SCIENCE

Co-Overexpression of GEP100 and AMAP1 Proteins Correlates with Rapid Local Recurrence after Breast Conservative Therapy

(2013) Rumiko Kinoshita et al.   PLoS One

Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

(2013) M. Yu et al.   SCIENCE

The evolving landscape of protein kinases in breast cancer: Clinical implications

(2012) Alberto Ocaña et al.   CANCER TREATMENT REVIEWS

Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway

(2012) William A. Freed-Pastor et al.   CELL

Rab5c promotes AMAP1–PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion

(2012) Yasuhito Onodera et al.   JOURNAL OF CELL BIOLOGY

The Controversies of Statin Therapy

(2012) J. Wouter Jukema et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

Geranylgeranyl Diphosphate Synthase: An Emerging Therapeutic Target

(2011) A J Wiemer et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The diversity of sex steroid action: regulation of metabolism by estrogen signaling

(2011) Malin Hedengran Faulds et al.   JOURNAL OF ENDOCRINOLOGY

GEP100-Arf6-AMAP1-Cortactin Pathway Frequently Used in Cancer Invasion Is Activated by VEGFR2 to Promote Angiogenesis

(2011) Ari Hashimoto et al.   PLoS One

Engagement of Overexpressed Her2 with GEP100 Induces Autonomous Invasive Activities and Provides a Biomarker for Metastases of Lung Adenocarcinoma

(2011) Toshi Menju et al.   PLoS One

Small GTPase Rab12 Regulates Constitutive Degradation of Transferrin Receptor

(2011) Takahide Matsui et al.   TRAFFIC

Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib

(2010) Mary E. Irwin et al.   JOURNAL OF CELLULAR PHYSIOLOGY

A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis

(2009) Maddalena Adorno et al.   CELL

Rab GTPases as coordinators of vesicle traffic

(2009) Harald Stenmark   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Pathways and mechanisms of endocytic recycling

(2009) Barth D. Grant et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

EPB41L5 functions to post-transcriptionally regulate cadherin and integrin during epithelial–mesenchymal transition

(2008) Mariko Hirano et al.   JOURNAL OF CELL BIOLOGY

Cancer survival in five continents: a worldwide population-based study (CONCORD)

(2008) Michel P Coleman et al.   LANCET ONCOLOGY